Ikarian Capital »

Abeona Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 600k 5.01

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Abeona Therapeutics

Nantahala Capital Management
Millennium Management
Vanguard Group
Western Standard
Point72 Asset Management
Ikarian Capital
Citigroup
J. Goldman & Co
Geode Capital Management
BlackRock
Walleye Trading Advisors
Barclays
Northern Trust
Bank of New York Mellon
Citadel Advisors

View all funds holding Abeona Therapeutics